BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1188176 Cc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C37H43N5O6S/c1-26-34-31-13-6-12-29-30(14-7-21-48-33-15-5-10-27-9-3-4-11-28(27)33)36(37(43)44)42(35(29)31)16-8-24-49(45,46)41(25-32(34)38-39(26)2)18-17-40-19-22-47-23-20-40/h3-6,9-13,15H,7-8,14,16-25H2,1-2H3,(H,43,44) AFRFRYZBRLJQPF-UHFFFAOYSA-N 562256 (rac)-2,3-Dimethyl-14-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 1::US11401278, Example 2::US11401278, Example 3 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 6.20 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562256&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591697 472623827 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188177 Cc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C37H43N5O6S/c1-26-34-31-13-6-12-29-30(14-7-21-48-33-15-5-10-27-9-3-4-11-28(27)33)36(37(43)44)42(35(29)31)16-8-24-49(45,46)41(25-32(34)38-39(26)2)18-17-40-19-22-47-23-20-40/h3-6,9-13,15H,7-8,14,16-25H2,1-2H3,(H,43,44) AFRFRYZBRLJQPF-UHFFFAOYSA-N 562256 (rac)-2,3-Dimethyl-14-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 1::US11401278, Example 2::US11401278, Example 3 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562256&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591697 472623827 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188178 Cc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C37H43N5O6S/c1-26-34-31-13-6-12-29-30(14-7-21-48-33-15-5-10-27-9-3-4-11-28(27)33)36(37(43)44)42(35(29)31)16-8-24-49(45,46)41(25-32(34)38-39(26)2)18-17-40-19-22-47-23-20-40/h3-6,9-13,15H,7-8,14,16-25H2,1-2H3,(H,43,44) AFRFRYZBRLJQPF-UHFFFAOYSA-N 562256 (rac)-2,3-Dimethyl-14-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 1::US11401278, Example 2::US11401278, Example 3 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562256&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591697 472623827 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188179 Cc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C37H43N5O6S/c1-26-34-31-13-6-12-29-30(14-7-21-48-33-15-5-10-27-9-3-4-11-28(27)33)36(37(43)44)42(35(29)31)16-8-24-49(45,46)41(25-32(34)38-39(26)2)18-17-40-19-22-47-23-20-40/h3-6,9-13,15H,7-8,14,16-25H2,1-2H3,(H,43,44) AFRFRYZBRLJQPF-UHFFFAOYSA-N 562256 (rac)-2,3-Dimethyl-14-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 1::US11401278, Example 2::US11401278, Example 3 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 3.40 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562256&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591697 472623827 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188180 Cc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C37H43N5O6S/c1-26-34-31-13-6-12-29-30(14-7-21-48-33-15-5-10-27-9-3-4-11-28(27)33)36(37(43)44)42(35(29)31)16-8-24-49(45,46)41(25-32(34)38-39(26)2)18-17-40-19-22-47-23-20-40/h3-6,9-13,15H,7-8,14,16-25H2,1-2H3,(H,43,44) AFRFRYZBRLJQPF-UHFFFAOYSA-N 562256 (rac)-2,3-Dimethyl-14-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 1::US11401278, Example 2::US11401278, Example 3 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562256&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591697 472623827 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188181 Cc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C37H43N5O6S/c1-26-34-31-13-6-12-29-30(14-7-21-48-33-15-5-10-27-9-3-4-11-28(27)33)36(37(43)44)42(35(29)31)16-8-24-49(45,46)41(25-32(34)38-39(26)2)18-17-40-19-22-47-23-20-40/h3-6,9-13,15H,7-8,14,16-25H2,1-2H3,(H,43,44) AFRFRYZBRLJQPF-UHFFFAOYSA-N 562256 (rac)-2,3-Dimethyl-14-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 1::US11401278, Example 2::US11401278, Example 3 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562256&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591697 472623827 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188182 Cc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C37H43N5O6S/c1-26-34-31-13-6-12-29-30(14-7-21-48-33-15-5-10-27-9-3-4-11-28(27)33)36(37(43)44)42(35(29)31)16-8-24-49(45,46)41(25-32(34)38-39(26)2)18-17-40-19-22-47-23-20-40/h3-6,9-13,15H,7-8,14,16-25H2,1-2H3,(H,43,44) AFRFRYZBRLJQPF-UHFFFAOYSA-N 562256 (rac)-2,3-Dimethyl-14-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 1::US11401278, Example 2::US11401278, Example 3 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 270 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562256&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591697 472623827 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188183 Cc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C37H43N5O6S/c1-26-34-31-13-6-12-29-30(14-7-21-48-33-15-5-10-27-9-3-4-11-28(27)33)36(37(43)44)42(35(29)31)16-8-24-49(45,46)41(25-32(34)38-39(26)2)18-17-40-19-22-47-23-20-40/h3-6,9-13,15H,7-8,14,16-25H2,1-2H3,(H,43,44) AFRFRYZBRLJQPF-UHFFFAOYSA-N 562256 (rac)-2,3-Dimethyl-14-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 1::US11401278, Example 2::US11401278, Example 3 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562256&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591697 472623827 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188184 Cc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C37H43N5O6S/c1-26-34-31-13-6-12-29-30(14-7-21-48-33-15-5-10-27-9-3-4-11-28(27)33)36(37(43)44)42(35(29)31)16-8-24-49(45,46)41(25-32(34)38-39(26)2)18-17-40-19-22-47-23-20-40/h3-6,9-13,15H,7-8,14,16-25H2,1-2H3,(H,43,44) AFRFRYZBRLJQPF-UHFFFAOYSA-N 562256 (rac)-2,3-Dimethyl-14-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 1::US11401278, Example 2::US11401278, Example 3 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562256&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591697 472623827 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188185 CN1Cc2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33ClN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) LXCUTDCCCXYPED-UHFFFAOYSA-N 562331 (rac)-4-Chloro-2,3,14-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 4::US11401278, Example 5::US11401278, Example 6 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.20 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562331&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591647 472623899 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188186 CN1Cc2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33ClN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) LXCUTDCCCXYPED-UHFFFAOYSA-N 562331 (rac)-4-Chloro-2,3,14-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 4::US11401278, Example 5::US11401278, Example 6 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562331&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591647 472623899 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188187 CN1Cc2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33ClN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) LXCUTDCCCXYPED-UHFFFAOYSA-N 562331 (rac)-4-Chloro-2,3,14-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 4::US11401278, Example 5::US11401278, Example 6 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562331&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591647 472623899 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188188 CN1Cc2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33ClN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) LXCUTDCCCXYPED-UHFFFAOYSA-N 562331 (rac)-4-Chloro-2,3,14-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 4::US11401278, Example 5::US11401278, Example 6 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.520 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562331&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591647 472623899 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188189 CN1Cc2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33ClN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) LXCUTDCCCXYPED-UHFFFAOYSA-N 562331 (rac)-4-Chloro-2,3,14-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 4::US11401278, Example 5::US11401278, Example 6 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562331&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591647 472623899 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188190 CN1Cc2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33ClN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) LXCUTDCCCXYPED-UHFFFAOYSA-N 562331 (rac)-4-Chloro-2,3,14-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 4::US11401278, Example 5::US11401278, Example 6 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562331&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591647 472623899 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188191 CN1Cc2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33ClN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) LXCUTDCCCXYPED-UHFFFAOYSA-N 562331 (rac)-4-Chloro-2,3,14-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 4::US11401278, Example 5::US11401278, Example 6 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 11.0 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562331&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591647 472623899 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188192 CN1Cc2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33ClN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) LXCUTDCCCXYPED-UHFFFAOYSA-N 562331 (rac)-4-Chloro-2,3,14-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 4::US11401278, Example 5::US11401278, Example 6 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562331&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591647 472623899 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188193 CN1Cc2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33ClN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) LXCUTDCCCXYPED-UHFFFAOYSA-N 562331 (rac)-4-Chloro-2,3,14-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid::US11401278, Example 4::US11401278, Example 5::US11401278, Example 6 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 18000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562331&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591647 472623899 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188194 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(35)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(34)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) JLKMBCSAJBVARW-UHFFFAOYSA-N 562334 (rac)-12-Ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 7 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.30 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562334&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591593 472623900 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188195 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(35)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(34)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) JLKMBCSAJBVARW-UHFFFAOYSA-N 562334 (rac)-12-Ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 7 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 18000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562334&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591593 472623900 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188196 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(35)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(34)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) JLKMBCSAJBVARW-UHFFFAOYSA-N 562334 (rac)-12-Ethyl-13-fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 7 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562334&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591593 472623900 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188197 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(35)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(34)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) JLKMBCSAJBVARW-UHFFFAOYSA-N 562335 (+)-3-Ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 8 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.70 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562335&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591593 472623901 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188198 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(35)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(34)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) JLKMBCSAJBVARW-UHFFFAOYSA-N 562335 (+)-3-Ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 8 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562335&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591593 472623901 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188199 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(35)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(34)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) JLKMBCSAJBVARW-UHFFFAOYSA-N 562335 (+)-3-Ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 8 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562335&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591593 472623901 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188200 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(35)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(34)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) JLKMBCSAJBVARW-UHFFFAOYSA-N 562336 (−)-3-Ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 9 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 34.0 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562336&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591593 472623902 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188201 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(35)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(34)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) JLKMBCSAJBVARW-UHFFFAOYSA-N 562336 (−)-3-Ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 9 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562336&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591593 472623902 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188202 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(35)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(34)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) JLKMBCSAJBVARW-UHFFFAOYSA-N 562336 (−)-3-Ethyl-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13λ6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 9 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562336&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591593 472623902 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188203 CN1Cc2nn(C)c(C)c2-c2cccc3C(CCCOc4cccc5ccccc45)=C(C(CCCS1(=O)=O)c23)C(O)=O InChI=1S/C33H35N3O5S/c1-21-30-26-14-7-13-24-25(15-8-18-41-29-17-6-11-22-10-4-5-12-23(22)29)32(33(37)38)27(31(24)26)16-9-19-42(39,40)35(2)20-28(30)34-36(21)3/h4-7,10-14,17,27H,8-9,15-16,18-20H2,1-3H3,(H,37,38) OAWARIQZWOSCIG-UHFFFAOYSA-N 562337 (rac)-2,3,14-Trimethyl-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 10 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 7.40 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562337&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 159940877 472623903 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188204 CN1Cc2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H34N4O5S/c1-21-29-26-14-7-13-24-25(15-8-18-41-28-16-6-11-22-10-4-5-12-23(22)28)31(32(37)38)36(30(24)26)17-9-19-42(39,40)34(2)20-27(29)33-35(21)3/h4-7,10-14,16H,8-9,15,17-20H2,1-3H3,(H,37,38) JYNTXMBHJAXDSH-UHFFFAOYSA-N 562338 (+)-2,3,14-Trimethyl-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide-N-ethylethanamine Salt (Enantiomer 1)::US11401278, Example 11 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 2.20 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562338&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591682 472623904 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188205 CN1Cc2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H34N4O5S/c1-21-29-26-14-7-13-24-25(15-8-18-41-28-16-6-11-22-10-4-5-12-23(22)28)31(32(37)38)36(30(24)26)17-9-19-42(39,40)34(2)20-27(29)33-35(21)3/h4-7,10-14,16H,8-9,15,17-20H2,1-3H3,(H,37,38) JYNTXMBHJAXDSH-UHFFFAOYSA-N 562338 (+)-2,3,14-Trimethyl-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide-N-ethylethanamine Salt (Enantiomer 1)::US11401278, Example 11 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562338&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591682 472623904 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188206 CN1Cc2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H34N4O5S/c1-21-29-26-14-7-13-24-25(15-8-18-41-28-16-6-11-22-10-4-5-12-23(22)28)31(32(37)38)36(30(24)26)17-9-19-42(39,40)34(2)20-27(29)33-35(21)3/h4-7,10-14,16H,8-9,15,17-20H2,1-3H3,(H,37,38) JYNTXMBHJAXDSH-UHFFFAOYSA-N 562338 (+)-2,3,14-Trimethyl-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide-N-ethylethanamine Salt (Enantiomer 1)::US11401278, Example 11 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562338&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591682 472623904 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188207 CN1Cc2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H34N4O5S/c1-21-29-26-14-7-13-24-25(15-8-18-41-28-16-6-11-22-10-4-5-12-23(22)28)31(32(37)38)36(30(24)26)17-9-19-42(39,40)34(2)20-27(29)33-35(21)3/h4-7,10-14,16H,8-9,15,17-20H2,1-3H3,(H,37,38) JYNTXMBHJAXDSH-UHFFFAOYSA-N 562339 (−)-2,3,14-Trimethyl-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide-N-ethylethanamine Salt (Enantiomer 2)::US11401278, Example 12 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 110 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562339&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591682 472623905 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188208 CN1Cc2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H34N4O5S/c1-21-29-26-14-7-13-24-25(15-8-18-41-28-16-6-11-22-10-4-5-12-23(22)28)31(32(37)38)36(30(24)26)17-9-19-42(39,40)34(2)20-27(29)33-35(21)3/h4-7,10-14,16H,8-9,15,17-20H2,1-3H3,(H,37,38) JYNTXMBHJAXDSH-UHFFFAOYSA-N 562339 (−)-2,3,14-Trimethyl-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide-N-ethylethanamine Salt (Enantiomer 2)::US11401278, Example 12 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562339&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591682 472623905 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188209 CN1Cc2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H34N4O5S/c1-21-29-26-14-7-13-24-25(15-8-18-41-28-16-6-11-22-10-4-5-12-23(22)28)31(32(37)38)36(30(24)26)17-9-19-42(39,40)34(2)20-27(29)33-35(21)3/h4-7,10-14,16H,8-9,15,17-20H2,1-3H3,(H,37,38) JYNTXMBHJAXDSH-UHFFFAOYSA-N 562339 (−)-2,3,14-Trimethyl-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide-N-ethylethanamine Salt (Enantiomer 2)::US11401278, Example 12 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 15000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562339&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591682 472623905 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188210 CCc1c-2c(CN(CCCN3CCCC3=O)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H45N5O6S/c1-3-33-36-31-16-7-15-29-30(17-9-24-50-34-18-6-13-27-12-4-5-14-28(27)34)38(39(46)47)44(37(29)31)23-11-25-51(48,49)43(26-32(36)40-41(33)2)22-10-21-42-20-8-19-35(42)45/h4-7,12-16,18H,3,8-11,17,19-26H2,1-2H3,(H,46,47) NIJIWJYCGDDSPR-UHFFFAOYSA-N 562340 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-8-(3-(2-oxopyrrolidin-1-yl)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 13 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 6.30 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562340&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591655 472623906 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188211 CCc1c-2c(CN(CCCN3CCCC3=O)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H45N5O6S/c1-3-33-36-31-16-7-15-29-30(17-9-24-50-34-18-6-13-27-12-4-5-14-28(27)34)38(39(46)47)44(37(29)31)23-11-25-51(48,49)43(26-32(36)40-41(33)2)22-10-21-42-20-8-19-35(42)45/h4-7,12-16,18H,3,8-11,17,19-26H2,1-2H3,(H,46,47) NIJIWJYCGDDSPR-UHFFFAOYSA-N 562340 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-8-(3-(2-oxopyrrolidin-1-yl)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 13 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562340&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591655 472623906 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188212 CCc1c-2c(CN(CCCN3CCCC3=O)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H45N5O6S/c1-3-33-36-31-16-7-15-29-30(17-9-24-50-34-18-6-13-27-12-4-5-14-28(27)34)38(39(46)47)44(37(29)31)23-11-25-51(48,49)43(26-32(36)40-41(33)2)22-10-21-42-20-8-19-35(42)45/h4-7,12-16,18H,3,8-11,17,19-26H2,1-2H3,(H,46,47) NIJIWJYCGDDSPR-UHFFFAOYSA-N 562340 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-8-(3-(2-oxopyrrolidin-1-yl)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 13 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562340&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591655 472623906 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188213 CCc1c-2c(CN(CCN3CCCCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H47N5O5S/c1-3-34-36-32-17-10-16-30-31(18-11-25-49-35-19-9-14-28-13-5-6-15-29(28)35)38(39(45)46)44(37(30)32)22-12-26-50(47,48)43(27-33(36)40-41(34)2)24-23-42-20-7-4-8-21-42/h5-6,9-10,13-17,19H,3-4,7-8,11-12,18,20-27H2,1-2H3,(H,45,46) YPGGFFJBRIALQS-UHFFFAOYSA-N 562341 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-8-(2-(piperidin-1-yl)ethyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide 2,2,2-trifluoroacetic acid salt::US11401278, Example 14 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 9.80 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562341&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591694 472623907 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188214 CCc1c-2c(CN(CCN3CCCCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H47N5O5S/c1-3-34-36-32-17-10-16-30-31(18-11-25-49-35-19-9-14-28-13-5-6-15-29(28)35)38(39(45)46)44(37(30)32)22-12-26-50(47,48)43(27-33(36)40-41(34)2)24-23-42-20-7-4-8-21-42/h5-6,9-10,13-17,19H,3-4,7-8,11-12,18,20-27H2,1-2H3,(H,45,46) YPGGFFJBRIALQS-UHFFFAOYSA-N 562341 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-8-(2-(piperidin-1-yl)ethyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide 2,2,2-trifluoroacetic acid salt::US11401278, Example 14 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562341&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591694 472623907 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188215 CCc1c-2c(CN(CCN3CCCCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H47N5O5S/c1-3-34-36-32-17-10-16-30-31(18-11-25-49-35-19-9-14-28-13-5-6-15-29(28)35)38(39(45)46)44(37(30)32)22-12-26-50(47,48)43(27-33(36)40-41(34)2)24-23-42-20-7-4-8-21-42/h5-6,9-10,13-17,19H,3-4,7-8,11-12,18,20-27H2,1-2H3,(H,45,46) YPGGFFJBRIALQS-UHFFFAOYSA-N 562341 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-8-(2-(piperidin-1-yl)ethyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide 2,2,2-trifluoroacetic acid salt::US11401278, Example 14 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562341&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591694 472623907 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188216 CCc1c-2c(CN(CCCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H47N5O6S/c1-3-34-36-32-15-7-14-30-31(16-8-23-50-35-17-6-12-28-11-4-5-13-29(28)35)38(39(45)46)44(37(30)32)20-10-26-51(47,48)43(27-33(36)40-41(34)2)19-9-18-42-21-24-49-25-22-42/h4-7,11-15,17H,3,8-10,16,18-27H2,1-2H3,(H,45,46) QNCNHCMKFPBURY-UHFFFAOYSA-N 562342 (rac)-12-Ethyl-11-methyl-8-(3-morpholinopropyl)-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide 2,2,2-trifluoroacetic acid salt::US11401278, Example 15 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 5.60 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562342&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591617 472623908 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188217 CCc1c-2c(CN(CCCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H47N5O6S/c1-3-34-36-32-15-7-14-30-31(16-8-23-50-35-17-6-12-28-11-4-5-13-29(28)35)38(39(45)46)44(37(30)32)20-10-26-51(47,48)43(27-33(36)40-41(34)2)19-9-18-42-21-24-49-25-22-42/h4-7,11-15,17H,3,8-10,16,18-27H2,1-2H3,(H,45,46) QNCNHCMKFPBURY-UHFFFAOYSA-N 562342 (rac)-12-Ethyl-11-methyl-8-(3-morpholinopropyl)-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide 2,2,2-trifluoroacetic acid salt::US11401278, Example 15 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562342&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591617 472623908 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188218 CCc1c-2c(CN(CCCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H47N5O6S/c1-3-34-36-32-15-7-14-30-31(16-8-23-50-35-17-6-12-28-11-4-5-13-29(28)35)38(39(45)46)44(37(30)32)20-10-26-51(47,48)43(27-33(36)40-41(34)2)19-9-18-42-21-24-49-25-22-42/h4-7,11-15,17H,3,8-10,16,18-27H2,1-2H3,(H,45,46) QNCNHCMKFPBURY-UHFFFAOYSA-N 562342 (rac)-12-Ethyl-11-methyl-8-(3-morpholinopropyl)-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide 2,2,2-trifluoroacetic acid salt::US11401278, Example 15 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562342&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591617 472623908 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188219 CCc1c-2c(CN(CCCN3CCCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H47N5O5S/c1-3-34-36-32-17-9-16-30-31(18-10-25-49-35-19-8-14-28-13-4-5-15-29(28)35)38(39(45)46)44(37(30)32)24-12-26-50(47,48)43(27-33(36)40-41(34)2)23-11-22-42-20-6-7-21-42/h4-5,8-9,13-17,19H,3,6-7,10-12,18,20-27H2,1-2H3,(H,45,46) RHZQBRFCPNPHHZ-UHFFFAOYSA-N 562343 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-8-(3-(pyrrolidin-1-yl)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 16 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 5.70 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562343&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591674 472623909 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188220 CCc1c-2c(CN(CCCN3CCCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H47N5O5S/c1-3-34-36-32-17-9-16-30-31(18-10-25-49-35-19-8-14-28-13-4-5-15-29(28)35)38(39(45)46)44(37(30)32)24-12-26-50(47,48)43(27-33(36)40-41(34)2)23-11-22-42-20-6-7-21-42/h4-5,8-9,13-17,19H,3,6-7,10-12,18,20-27H2,1-2H3,(H,45,46) RHZQBRFCPNPHHZ-UHFFFAOYSA-N 562343 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-8-(3-(pyrrolidin-1-yl)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 16 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562343&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591674 472623909 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188221 CCc1c-2c(CN(CCCN3CCCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C39H47N5O5S/c1-3-34-36-32-17-9-16-30-31(18-10-25-49-35-19-8-14-28-13-4-5-15-29(28)35)38(39(45)46)44(37(30)32)24-12-26-50(47,48)43(27-33(36)40-41(34)2)23-11-22-42-20-6-7-21-42/h4-5,8-9,13-17,19H,3,6-7,10-12,18,20-27H2,1-2H3,(H,45,46) RHZQBRFCPNPHHZ-UHFFFAOYSA-N 562343 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-8-(3-(pyrrolidin-1-yl)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 16 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562343&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591674 472623909 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188222 CCc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C32H34N4O5S/c1-3-27-29-25-14-7-13-23-24(15-8-18-41-28-16-6-11-21-10-4-5-12-22(21)28)31(32(37)38)36(30(23)25)17-9-19-42(39,40)33-20-26(29)34-35(27)2/h4-7,10-14,16,33H,3,8-9,15,17-20H2,1-2H3,(H,37,38) WSCLIUZENSUOMD-UHFFFAOYSA-N 562344 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 17 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 8.10 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562344&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591712 472623910 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188223 CCc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C32H34N4O5S/c1-3-27-29-25-14-7-13-23-24(15-8-18-41-28-16-6-11-21-10-4-5-12-22(21)28)31(32(37)38)36(30(23)25)17-9-19-42(39,40)33-20-26(29)34-35(27)2/h4-7,10-14,16,33H,3,8-9,15,17-20H2,1-2H3,(H,37,38) WSCLIUZENSUOMD-UHFFFAOYSA-N 562344 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 17 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562344&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591712 472623910 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188224 CCc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc-2c34)nn1C InChI=1S/C32H34N4O5S/c1-3-27-29-25-14-7-13-23-24(15-8-18-41-28-16-6-11-21-10-4-5-12-22(21)28)31(32(37)38)36(30(23)25)17-9-19-42(39,40)33-20-26(29)34-35(27)2/h4-7,10-14,16,33H,3,8-9,15,17-20H2,1-2H3,(H,37,38) WSCLIUZENSUOMD-UHFFFAOYSA-N 562344 (rac)-12-Ethyl-11-methyl-1-(3-(naphthalen-1-yloxy)propyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 17 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562344&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591712 472623910 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188225 CCc1c-2c(nn1C)C(C)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc-2c13 InChI=1S/C34H38N4O5S/c1-5-28-30-27-16-9-15-25-26(17-10-20-43-29-18-8-13-23-12-6-7-14-24(23)29)33(34(39)40)38(32(25)27)19-11-21-44(41,42)37(4)22(2)31(30)35-36(28)3/h6-9,12-16,18,22H,5,10-11,17,19-21H2,1-4H3,(H,39,40) CYAZPSVAIWRWMS-UHFFFAOYSA-N 562345 12-Ethyl-8,9,11-trimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide (Mixture of Stereoisomers)::US11401278, Example 18 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 7.80 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562345&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 157725870 472623911 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188226 CCc1c-2c(nn1C)C(C)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc-2c13 InChI=1S/C34H38N4O5S/c1-5-28-30-27-16-9-15-25-26(17-10-20-43-29-18-8-13-23-12-6-7-14-24(23)29)33(34(39)40)38(32(25)27)19-11-21-44(41,42)37(4)22(2)31(30)35-36(28)3/h6-9,12-16,18,22H,5,10-11,17,19-21H2,1-4H3,(H,39,40) CYAZPSVAIWRWMS-UHFFFAOYSA-N 562345 12-Ethyl-8,9,11-trimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide (Mixture of Stereoisomers)::US11401278, Example 18 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562345&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 157725870 472623911 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188227 CCc1c-2c(nn1C)C(C)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4ccccc34)c3cccc-2c13 InChI=1S/C34H38N4O5S/c1-5-28-30-27-16-9-15-25-26(17-10-20-43-29-18-8-13-23-12-6-7-14-24(23)29)33(34(39)40)38(32(25)27)19-11-21-44(41,42)37(4)22(2)31(30)35-36(28)3/h6-9,12-16,18,22H,5,10-11,17,19-21H2,1-4H3,(H,39,40) CYAZPSVAIWRWMS-UHFFFAOYSA-N 562345 12-Ethyl-8,9,11-trimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide (Mixture of Stereoisomers)::US11401278, Example 18 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562345&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 157725870 472623911 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188228 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562346 (rac)-13-Chloro-12-ethyl-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 19 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.80 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562346&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623912 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188229 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562346 (rac)-13-Chloro-12-ethyl-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 19 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562346&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623912 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188230 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562346 (rac)-13-Chloro-12-ethyl-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 19 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562346&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623912 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188231 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H35ClN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h5-7,10-12,14-16H,4,8-9,13,17-20H2,1-3H3,(H,39,40) UILUNEMOIATZDC-UHFFFAOYSA-N 562347 (rac)-13-Chloro-12-ethyl-8,11-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 20 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 2.70 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562347&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591652 472623913 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188232 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H35ClN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h5-7,10-12,14-16H,4,8-9,13,17-20H2,1-3H3,(H,39,40) UILUNEMOIATZDC-UHFFFAOYSA-N 562347 (rac)-13-Chloro-12-ethyl-8,11-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 20 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562347&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591652 472623913 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188233 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H35ClN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h5-7,10-12,14-16H,4,8-9,13,17-20H2,1-3H3,(H,39,40) UILUNEMOIATZDC-UHFFFAOYSA-N 562347 (rac)-13-Chloro-12-ethyl-8,11-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 20 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562347&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591652 472623913 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188234 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H37ClN4O5S/c1-4-26-29-25(34-36(26)3)19-35(2)43(40,41)18-8-16-37-30-23(14-15-24(33)28(29)30)22(31(37)32(38)39)12-7-17-42-27-13-6-10-20-9-5-11-21(20)27/h6,10,13-15H,4-5,7-9,11-12,16-19H2,1-3H3,(H,38,39) QSTFAKZLOCCPHY-UHFFFAOYSA-N 562348 (rac)-13-Chloro-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-12-ethyl-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 21 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.70 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562348&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 160508660 472623914 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188235 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H37ClN4O5S/c1-4-26-29-25(34-36(26)3)19-35(2)43(40,41)18-8-16-37-30-23(14-15-24(33)28(29)30)22(31(37)32(38)39)12-7-17-42-27-13-6-10-20-9-5-11-21(20)27/h6,10,13-15H,4-5,7-9,11-12,16-19H2,1-3H3,(H,38,39) QSTFAKZLOCCPHY-UHFFFAOYSA-N 562348 (rac)-13-Chloro-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-12-ethyl-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 21 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562348&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 160508660 472623914 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188236 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H37ClN4O5S/c1-4-26-29-25(34-36(26)3)19-35(2)43(40,41)18-8-16-37-30-23(14-15-24(33)28(29)30)22(31(37)32(38)39)12-7-17-42-27-13-6-10-20-9-5-11-21(20)27/h6,10,13-15H,4-5,7-9,11-12,16-19H2,1-3H3,(H,38,39) QSTFAKZLOCCPHY-UHFFFAOYSA-N 562348 (rac)-13-Chloro-1-(3-((2,3-dihydro-1H-inden-4-yl)oxy)propyl)-12-ethyl-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 21 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562348&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 160508660 472623914 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188237 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H36Cl2N4O5S/c1-6-25-27-24(34-36(25)5)17-35(4)43(40,41)14-8-12-37-29-22(10-11-23(32)26(27)29)21(30(37)31(38)39)9-7-13-42-20-15-18(2)28(33)19(3)16-20/h10-11,15-16H,6-9,12-14,17H2,1-5H3,(H,38,39) JCQBQOUTDBRDMH-UHFFFAOYSA-N 562349 (rac)-13-Chloro-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-8,11-dimethyl-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 22 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 3.10 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562349&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591634 472623915 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188238 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H36Cl2N4O5S/c1-6-25-27-24(34-36(25)5)17-35(4)43(40,41)14-8-12-37-29-22(10-11-23(32)26(27)29)21(30(37)31(38)39)9-7-13-42-20-15-18(2)28(33)19(3)16-20/h10-11,15-16H,6-9,12-14,17H2,1-5H3,(H,38,39) JCQBQOUTDBRDMH-UHFFFAOYSA-N 562349 (rac)-13-Chloro-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-8,11-dimethyl-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 22 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562349&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591634 472623915 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188239 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H36Cl2N4O5S/c1-6-25-27-24(34-36(25)5)17-35(4)43(40,41)14-8-12-37-29-22(10-11-23(32)26(27)29)21(30(37)31(38)39)9-7-13-42-20-15-18(2)28(33)19(3)16-20/h10-11,15-16H,6-9,12-14,17H2,1-5H3,(H,38,39) JCQBQOUTDBRDMH-UHFFFAOYSA-N 562349 (rac)-13-Chloro-1-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-8,11-dimethyl-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 22 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562349&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591634 472623915 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188240 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H39ClN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h7,11,14-16H,4-6,8-10,12-13,17-20H2,1-3H3,(H,39,40) BVTZNGFTQCBWSN-UHFFFAOYSA-N 562350 (rac)-13-Chloro-12-ethyl-8,11-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 23 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 3.30 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562350&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591584 472623916 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188241 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H39ClN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h7,11,14-16H,4-6,8-10,12-13,17-20H2,1-3H3,(H,39,40) BVTZNGFTQCBWSN-UHFFFAOYSA-N 562350 (rac)-13-Chloro-12-ethyl-8,11-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 23 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 15000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562350&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591584 472623916 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188242 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H39ClN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h7,11,14-16H,4-6,8-10,12-13,17-20H2,1-3H3,(H,39,40) BVTZNGFTQCBWSN-UHFFFAOYSA-N 562350 (rac)-13-Chloro-12-ethyl-8,11-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 23 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562350&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591584 472623916 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188243 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)18-8-16-39-31-23(12-13-24(34)29(30)31)22(32(39)33(40)41)11-7-17-44-28-15-14-25(35)20-9-5-6-10-21(20)28/h5-6,9-10,12-15H,4,7-8,11,16-19H2,1-3H3,(H,40,41) BTWHAJJIYQNJBO-UHFFFAOYSA-N 562351 (rac)-13-Chloro-12-ethyl-1-(34(4-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 24 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 3.40 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562351&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591622 472623917 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188244 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)18-8-16-39-31-23(12-13-24(34)29(30)31)22(32(39)33(40)41)11-7-17-44-28-15-14-25(35)20-9-5-6-10-21(20)28/h5-6,9-10,12-15H,4,7-8,11,16-19H2,1-3H3,(H,40,41) BTWHAJJIYQNJBO-UHFFFAOYSA-N 562351 (rac)-13-Chloro-12-ethyl-1-(34(4-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 24 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562351&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591622 472623917 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188245 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)18-8-16-39-31-23(12-13-24(34)29(30)31)22(32(39)33(40)41)11-7-17-44-28-15-14-25(35)20-9-5-6-10-21(20)28/h5-6,9-10,12-15H,4,7-8,11,16-19H2,1-3H3,(H,40,41) BTWHAJJIYQNJBO-UHFFFAOYSA-N 562351 (rac)-13-Chloro-12-ethyl-1-(34(4-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-4,5,6,8,9,11-hexahydropyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 24 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562351&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591622 472623917 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188246 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)16-6-14-38-30-24(12-13-25(34)29(28)30)23(31(38)32(39)40)8-5-15-43-27-9-4-7-20-17-21(33)10-11-22(20)27/h4,7,9-13,17H,5-6,8,14-16,18H2,1-3H3,(H,39,40) SFAUIQOMBNEQSP-UHFFFAOYSA-N 562352 (rac)-13-Fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 25 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.70 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562352&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591560 472623918 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188247 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)16-6-14-38-30-24(12-13-25(34)29(28)30)23(31(38)32(39)40)8-5-15-43-27-9-4-7-20-17-21(33)10-11-22(20)27/h4,7,9-13,17H,5-6,8,14-16,18H2,1-3H3,(H,39,40) SFAUIQOMBNEQSP-UHFFFAOYSA-N 562352 (rac)-13-Fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 25 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562352&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591560 472623918 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188248 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)16-6-14-38-30-24(12-13-25(34)29(28)30)23(31(38)32(39)40)8-5-15-43-27-9-4-7-20-17-21(33)10-11-22(20)27/h4,7,9-13,17H,5-6,8,14-16,18H2,1-3H3,(H,39,40) SFAUIQOMBNEQSP-UHFFFAOYSA-N 562352 (rac)-13-Fluoro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 25 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562352&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591560 472623918 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188249 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33FN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) KFUZFZBOVQWXEU-UHFFFAOYSA-N 562353 (rac)-13-Fluoro-8,11,12-trimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 26 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 3.60 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562353&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591635 472623919 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188250 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33FN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) KFUZFZBOVQWXEU-UHFFFAOYSA-N 562353 (rac)-13-Fluoro-8,11,12-trimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 26 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562353&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591635 472623919 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188251 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H33FN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) KFUZFZBOVQWXEU-UHFFFAOYSA-N 562353 (rac)-13-Fluoro-8,11,12-trimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 26 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562353&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591635 472623919 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188252 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5CCCc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C31H35FN4O5S/c1-19-27-25(33-35(19)3)18-34(2)42(39,40)17-7-15-36-29-23(13-14-24(32)28(27)29)22(30(36)31(37)38)11-6-16-41-26-12-5-9-20-8-4-10-21(20)26/h5,9,12-14H,4,6-8,10-11,15-18H2,1-3H3,(H,37,38) TUUSACXFNUFQKW-UHFFFAOYSA-N 562354 (rac)-1-(3-((2,3-Dihydro-1H-inden-4-yl)oxy)propyl)-13-fluoro-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 27 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 2.10 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562354&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591588 472623920 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188253 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5CCCc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C31H35FN4O5S/c1-19-27-25(33-35(19)3)18-34(2)42(39,40)17-7-15-36-29-23(13-14-24(32)28(27)29)22(30(36)31(37)38)11-6-16-41-26-12-5-9-20-8-4-10-21(20)26/h5,9,12-14H,4,6-8,10-11,15-18H2,1-3H3,(H,37,38) TUUSACXFNUFQKW-UHFFFAOYSA-N 562354 (rac)-1-(3-((2,3-Dihydro-1H-inden-4-yl)oxy)propyl)-13-fluoro-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 27 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562354&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591588 472623920 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188254 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5CCCc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C31H35FN4O5S/c1-19-27-25(33-35(19)3)18-34(2)42(39,40)17-7-15-36-29-23(13-14-24(32)28(27)29)22(30(36)31(37)38)11-6-16-41-26-12-5-9-20-8-4-10-21(20)26/h5,9,12-14H,4,6-8,10-11,15-18H2,1-3H3,(H,37,38) TUUSACXFNUFQKW-UHFFFAOYSA-N 562354 (rac)-1-(3-((2,3-Dihydro-1H-inden-4-yl)oxy)propyl)-13-fluoro-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 27 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562354&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591588 472623920 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188255 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cc(C)c(Cl)c(C)c4)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C30H34ClFN4O5S/c1-17-14-20(15-18(2)27(17)31)41-12-6-8-21-22-9-10-23(32)26-25-19(3)35(5)33-24(25)16-34(4)42(39,40)13-7-11-36(28(22)26)29(21)30(37)38/h9-10,14-15H,6-8,11-13,16H2,1-5H3,(H,37,38) JNQZXBDFQCIYEW-UHFFFAOYSA-N 562355 (rac)-1-(3-(4-Chloro-3,5-dimethylphenoxy)propyl)-13-fluoro-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 28 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 4.00 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562355&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591638 472623921 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188256 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cc(C)c(Cl)c(C)c4)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C30H34ClFN4O5S/c1-17-14-20(15-18(2)27(17)31)41-12-6-8-21-22-9-10-23(32)26-25-19(3)35(5)33-24(25)16-34(4)42(39,40)13-7-11-36(28(22)26)29(21)30(37)38/h9-10,14-15H,6-8,11-13,16H2,1-5H3,(H,37,38) JNQZXBDFQCIYEW-UHFFFAOYSA-N 562355 (rac)-1-(3-(4-Chloro-3,5-dimethylphenoxy)propyl)-13-fluoro-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 28 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562355&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591638 472623921 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188257 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cc(C)c(Cl)c(C)c4)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C30H34ClFN4O5S/c1-17-14-20(15-18(2)27(17)31)41-12-6-8-21-22-9-10-23(32)26-25-19(3)35(5)33-24(25)16-34(4)42(39,40)13-7-11-36(28(22)26)29(21)30(37)38/h9-10,14-15H,6-8,11-13,16H2,1-5H3,(H,37,38) JNQZXBDFQCIYEW-UHFFFAOYSA-N 562355 (rac)-1-(3-(4-Chloro-3,5-dimethylphenoxy)propyl)-13-fluoro-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 28 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562355&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591638 472623921 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188258 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5CCCCc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H37FN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h6,10,13-15H,4-5,7-9,11-12,16-19H2,1-3H3,(H,38,39) YHNWKRBVQRJLLM-UHFFFAOYSA-N 562356 (rac)-13-Fluoro-8,11,12-trimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 29 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 3.10 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562356&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 161917486 472623922 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188259 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5CCCCc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H37FN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h6,10,13-15H,4-5,7-9,11-12,16-19H2,1-3H3,(H,38,39) YHNWKRBVQRJLLM-UHFFFAOYSA-N 562356 (rac)-13-Fluoro-8,11,12-trimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 29 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562356&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 161917486 472623922 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188260 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5CCCCc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H37FN4O5S/c1-20-28-26(34-36(20)3)19-35(2)43(40,41)18-8-16-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-17-42-27-13-6-10-21-9-4-5-11-22(21)27/h6,10,13-15H,4-5,7-9,11-12,16-19H2,1-3H3,(H,38,39) YHNWKRBVQRJLLM-UHFFFAOYSA-N 562356 (rac)-13-Fluoro-8,11,12-trimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 29 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562356&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 161917486 472623922 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188261 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4ccc(F)c5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)17-7-15-38-30-23(11-12-25(34)29(28)30)22(31(38)32(39)40)10-6-16-43-27-14-13-24(33)20-8-4-5-9-21(20)27/h4-5,8-9,11-14H,6-7,10,15-18H2,1-3H3,(H,39,40) AFBLJVYGJLJLNH-UHFFFAOYSA-N 562357 (rac)-13-Fluoro-1-(34(4-fluoronaphthalen-1-yl)oxy)propyl)-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 30 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 5.10 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562357&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591596 472623923 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188262 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4ccc(F)c5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)17-7-15-38-30-23(11-12-25(34)29(28)30)22(31(38)32(39)40)10-6-16-43-27-14-13-24(33)20-8-4-5-9-21(20)27/h4-5,8-9,11-14H,6-7,10,15-18H2,1-3H3,(H,39,40) AFBLJVYGJLJLNH-UHFFFAOYSA-N 562357 (rac)-13-Fluoro-1-(34(4-fluoronaphthalen-1-yl)oxy)propyl)-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 30 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562357&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591596 472623923 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188263 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4ccc(F)c5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)17-7-15-38-30-23(11-12-25(34)29(28)30)22(31(38)32(39)40)10-6-16-43-27-14-13-24(33)20-8-4-5-9-21(20)27/h4-5,8-9,11-14H,6-7,10,15-18H2,1-3H3,(H,39,40) AFBLJVYGJLJLNH-UHFFFAOYSA-N 562357 (rac)-13-Fluoro-1-(34(4-fluoronaphthalen-1-yl)oxy)propyl)-8,11,12-trimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 30 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562357&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591596 472623923 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188264 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H35FN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h5-7,10-12,14-16H,4,8-9,13,17-20H2,1-3H3,(H,39,40) LGDNUBUBCXSVJZ-UHFFFAOYSA-N 562358 (rac)-12-Ethyl-13-fluoro-8,11-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 31 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 3.60 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562358&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 159341117 472623924 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188265 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H35FN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h5-7,10-12,14-16H,4,8-9,13,17-20H2,1-3H3,(H,39,40) LGDNUBUBCXSVJZ-UHFFFAOYSA-N 562358 (rac)-12-Ethyl-13-fluoro-8,11-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 31 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562358&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 159341117 472623924 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188266 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H35FN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h5-7,10-12,14-16H,4,8-9,13,17-20H2,1-3H3,(H,39,40) LGDNUBUBCXSVJZ-UHFFFAOYSA-N 562358 (rac)-12-Ethyl-13-fluoro-8,11-dimethyl-1-(3-(naphthalen-1-yloxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 31 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562358&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 159341117 472623924 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188267 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H37FN4O5S/c1-4-26-29-25(34-36(26)3)19-35(2)43(40,41)18-8-16-37-30-23(14-15-24(33)28(29)30)22(31(37)32(38)39)12-7-17-42-27-13-6-10-20-9-5-11-21(20)27/h6,10,13-15H,4-5,7-9,11-12,16-19H2,1-3H3,(H,38,39) OIGDWZBUMLBHPF-UHFFFAOYSA-N 562359 (rac)-1-(3-((2,3-Dihydro-1H-inden-4-yl)oxy)propyl)-12-ethyl-13-fluoro-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 32 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.50 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562359&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591579 472623925 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188268 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H37FN4O5S/c1-4-26-29-25(34-36(26)3)19-35(2)43(40,41)18-8-16-37-30-23(14-15-24(33)28(29)30)22(31(37)32(38)39)12-7-17-42-27-13-6-10-20-9-5-11-21(20)27/h6,10,13-15H,4-5,7-9,11-12,16-19H2,1-3H3,(H,38,39) OIGDWZBUMLBHPF-UHFFFAOYSA-N 562359 (rac)-1-(3-((2,3-Dihydro-1H-inden-4-yl)oxy)propyl)-12-ethyl-13-fluoro-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 32 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562359&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591579 472623925 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188269 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C32H37FN4O5S/c1-4-26-29-25(34-36(26)3)19-35(2)43(40,41)18-8-16-37-30-23(14-15-24(33)28(29)30)22(31(37)32(38)39)12-7-17-42-27-13-6-10-20-9-5-11-21(20)27/h6,10,13-15H,4-5,7-9,11-12,16-19H2,1-3H3,(H,38,39) OIGDWZBUMLBHPF-UHFFFAOYSA-N 562359 (rac)-1-(3-((2,3-Dihydro-1H-inden-4-yl)oxy)propyl)-12-ethyl-13-fluoro-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 32 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562359&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591579 472623925 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188270 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c-2c34)nn1C InChI=1S/C31H36ClFN4O5S/c1-6-25-27-24(34-36(25)5)17-35(4)43(40,41)14-8-12-37-29-22(10-11-23(33)26(27)29)21(30(37)31(38)39)9-7-13-42-20-15-18(2)28(32)19(3)16-20/h10-11,15-16H,6-9,12-14,17H2,1-5H3,(H,38,39) WHNULKKLRWUHEO-UHFFFAOYSA-N 562360 (rac)-1-(3-(4-Chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-13-fluoro-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 33 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 4.20 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562360&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 161506633 472623926 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188271 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c-2c34)nn1C InChI=1S/C31H36ClFN4O5S/c1-6-25-27-24(34-36(25)5)17-35(4)43(40,41)14-8-12-37-29-22(10-11-23(33)26(27)29)21(30(37)31(38)39)9-7-13-42-20-15-18(2)28(32)19(3)16-20/h10-11,15-16H,6-9,12-14,17H2,1-5H3,(H,38,39) WHNULKKLRWUHEO-UHFFFAOYSA-N 562360 (rac)-1-(3-(4-Chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-13-fluoro-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 33 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562360&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 161506633 472623926 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188272 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cc(C)c(Cl)c(C)c4)c4ccc(F)c-2c34)nn1C InChI=1S/C31H36ClFN4O5S/c1-6-25-27-24(34-36(25)5)17-35(4)43(40,41)14-8-12-37-29-22(10-11-23(33)26(27)29)21(30(37)31(38)39)9-7-13-42-20-15-18(2)28(32)19(3)16-20/h10-11,15-16H,6-9,12-14,17H2,1-5H3,(H,38,39) WHNULKKLRWUHEO-UHFFFAOYSA-N 562360 (rac)-1-(3-(4-Chloro-3,5-dimethylphenoxy)propyl)-12-ethyl-13-fluoro-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 33 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562360&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 161506633 472623926 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188273 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H39FN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h7,11,14-16H,4-6,8-10,12-13,17-20H2,1-3H3,(H,39,40) FKAGRCLTDGXTDL-UHFFFAOYSA-N 562361 (rac)-12-Ethyl-13-fluoro-8,11-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 34 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 3.20 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562361&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591679 472623927 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188274 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H39FN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h7,11,14-16H,4-6,8-10,12-13,17-20H2,1-3H3,(H,39,40) FKAGRCLTDGXTDL-UHFFFAOYSA-N 562361 (rac)-12-Ethyl-13-fluoro-8,11-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 34 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562361&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591679 472623927 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188275 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5CCCCc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H39FN4O5S/c1-4-27-30-26(35-37(27)3)20-36(2)44(41,42)19-9-17-38-31-24(15-16-25(34)29(30)31)23(32(38)33(39)40)13-8-18-43-28-14-7-11-21-10-5-6-12-22(21)28/h7,11,14-16H,4-6,8-10,12-13,17-20H2,1-3H3,(H,39,40) FKAGRCLTDGXTDL-UHFFFAOYSA-N 562361 (rac)-12-Ethyl-13-fluoro-8,11-dimethyl-1-(3-((5,6,7,8-tetrahydronaphthalen-1-yl)oxy)propyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 34 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562361&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591679 472623927 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188276 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)18-8-16-39-31-23(12-13-25(35)29(30)31)22(32(39)33(40)41)11-7-17-44-28-15-14-24(34)20-9-5-6-10-21(20)28/h5-6,9-10,12-15H,4,7-8,11,16-19H2,1-3H3,(H,40,41) KLWXNVSXOJTWQU-UHFFFAOYSA-N 562362 (rac)-12-Ethyl-13-fluoro-1-(34(4-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 35 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 3.50 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562362&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591688 472623928 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188277 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)18-8-16-39-31-23(12-13-25(35)29(30)31)22(32(39)33(40)41)11-7-17-44-28-15-14-24(34)20-9-5-6-10-21(20)28/h5-6,9-10,12-15H,4,7-8,11,16-19H2,1-3H3,(H,40,41) KLWXNVSXOJTWQU-UHFFFAOYSA-N 562362 (rac)-12-Ethyl-13-fluoro-1-(34(4-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 35 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562362&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591688 472623928 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188278 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4ccc(F)c5ccccc45)c4ccc(F)c-2c34)nn1C InChI=1S/C33H34F2N4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)18-8-16-39-31-23(12-13-25(35)29(30)31)22(32(39)33(40)41)11-7-17-44-28-15-14-24(34)20-9-5-6-10-21(20)28/h5-6,9-10,12-15H,4,7-8,11,16-19H2,1-3H3,(H,40,41) KLWXNVSXOJTWQU-UHFFFAOYSA-N 562362 (rac)-12-Ethyl-13-fluoro-1-(34(4-fluoronaphthalen-1-yl)oxy)propyl)-8,11-dimethyl-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3′,4′:4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 35 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562362&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591688 472623928 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188279 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562363 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 36 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.600 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562363&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623929 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188280 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562363 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 36 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 18000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562363&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623929 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188281 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562363 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 36 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562363&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623929 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188282 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562364 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 37 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 11.0 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562364&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623930 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188283 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562364 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 37 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562364&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623930 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188284 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562364 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 37 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 18000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562364&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623930 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188285 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)16-6-14-38-30-24(12-13-25(34)29(28)30)23(31(38)32(39)40)8-5-15-43-27-9-4-7-20-17-21(33)10-11-22(20)27/h4,7,9-13,17H,5-6,8,14-16,18H2,1-3H3,(H,39,40) SFAUIQOMBNEQSP-UHFFFAOYSA-N 562365 (−)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 38 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 23.0 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562365&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591560 472623931 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188286 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)16-6-14-38-30-24(12-13-25(34)29(28)30)23(31(38)32(39)40)8-5-15-43-27-9-4-7-20-17-21(33)10-11-22(20)27/h4,7,9-13,17H,5-6,8,14-16,18H2,1-3H3,(H,39,40) SFAUIQOMBNEQSP-UHFFFAOYSA-N 562365 (−)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 38 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562365&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591560 472623931 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188287 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)16-6-14-38-30-24(12-13-25(34)29(28)30)23(31(38)32(39)40)8-5-15-43-27-9-4-7-20-17-21(33)10-11-22(20)27/h4,7,9-13,17H,5-6,8,14-16,18H2,1-3H3,(H,39,40) SFAUIQOMBNEQSP-UHFFFAOYSA-N 562365 (−)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 38 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562365&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591560 472623931 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188288 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)16-6-14-38-30-24(12-13-25(34)29(28)30)23(31(38)32(39)40)8-5-15-43-27-9-4-7-20-17-21(33)10-11-22(20)27/h4,7,9-13,17H,5-6,8,14-16,18H2,1-3H3,(H,39,40) SFAUIQOMBNEQSP-UHFFFAOYSA-N 562366 (+)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 39 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.890 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562366&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591560 472623932 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188289 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)16-6-14-38-30-24(12-13-25(34)29(28)30)23(31(38)32(39)40)8-5-15-43-27-9-4-7-20-17-21(33)10-11-22(20)27/h4,7,9-13,17H,5-6,8,14-16,18H2,1-3H3,(H,39,40) SFAUIQOMBNEQSP-UHFFFAOYSA-N 562366 (+)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 39 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562366&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591560 472623932 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188290 CN1Cc2nn(C)c(C)c2-c2c(F)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C32H32F2N4O5S/c1-19-28-26(35-37(19)3)18-36(2)44(41,42)16-6-14-38-30-24(12-13-25(34)29(28)30)23(31(38)32(39)40)8-5-15-43-27-9-4-7-20-17-21(33)10-11-22(20)27/h4,7,9-13,17H,5-6,8,14-16,18H2,1-3H3,(H,39,40) SFAUIQOMBNEQSP-UHFFFAOYSA-N 562366 (+)-4-fluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino-[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 39 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562366&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591560 472623932 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188291 Cc1[nH]nc2CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClN4O5S/c1-20-29-27(36-35-20)19-38(22-12-13-22)44(41,42)18-6-16-37-31-25(14-15-26(34)30(29)31)24(32(37)33(39)40)10-5-17-43-28-11-4-8-21-7-2-3-9-23(21)28/h2-4,7-9,11,14-15,22H,5-6,10,12-13,16-19H2,1H3,(H,35,36)(H,39,40) HABXBCFVEWAMPQ-UHFFFAOYSA-N 562367 (rac)-4-chloro-14-cyclopropyl-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 40 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 2.10 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562367&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591616 472623933 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188292 Cc1[nH]nc2CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClN4O5S/c1-20-29-27(36-35-20)19-38(22-12-13-22)44(41,42)18-6-16-37-31-25(14-15-26(34)30(29)31)24(32(37)33(39)40)10-5-17-43-28-11-4-8-21-7-2-3-9-23(21)28/h2-4,7-9,11,14-15,22H,5-6,10,12-13,16-19H2,1H3,(H,35,36)(H,39,40) HABXBCFVEWAMPQ-UHFFFAOYSA-N 562367 (rac)-4-chloro-14-cyclopropyl-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 40 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562367&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591616 472623933 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188293 Cc1[nH]nc2CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClN4O5S/c1-20-29-27(36-35-20)19-38(22-12-13-22)44(41,42)18-6-16-37-31-25(14-15-26(34)30(29)31)24(32(37)33(39)40)10-5-17-43-28-11-4-8-21-7-2-3-9-23(21)28/h2-4,7-9,11,14-15,22H,5-6,10,12-13,16-19H2,1H3,(H,35,36)(H,39,40) HABXBCFVEWAMPQ-UHFFFAOYSA-N 562367 (rac)-4-chloro-14-cyclopropyl-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 40 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 19000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562367&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591616 472623933 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188294 Cc1[nH]nc2CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H32ClFN4O5S/c1-19-29-27(37-36-19)18-39(22-9-10-22)45(42,43)16-4-14-38-31-25(12-13-26(34)30(29)31)24(32(38)33(40)41)6-3-15-44-28-7-2-5-20-17-21(35)8-11-23(20)28/h2,5,7-8,11-13,17,22H,3-4,6,9-10,14-16,18H2,1H3,(H,36,37)(H,40,41) WKYSHCNOGACJHS-UHFFFAOYSA-N 562368 (rac)-4-chloro-14-cyclopropyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 41 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.30 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562368&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591571 472623934 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188295 Cc1[nH]nc2CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H32ClFN4O5S/c1-19-29-27(37-36-19)18-39(22-9-10-22)45(42,43)16-4-14-38-31-25(12-13-26(34)30(29)31)24(32(38)33(40)41)6-3-15-44-28-7-2-5-20-17-21(35)8-11-23(20)28/h2,5,7-8,11-13,17,22H,3-4,6,9-10,14-16,18H2,1H3,(H,36,37)(H,40,41) WKYSHCNOGACJHS-UHFFFAOYSA-N 562368 (rac)-4-chloro-14-cyclopropyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 41 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 19000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562368&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591571 472623934 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188296 Cc1[nH]nc2CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H32ClFN4O5S/c1-19-29-27(37-36-19)18-39(22-9-10-22)45(42,43)16-4-14-38-31-25(12-13-26(34)30(29)31)24(32(38)33(40)41)6-3-15-44-28-7-2-5-20-17-21(35)8-11-23(20)28/h2,5,7-8,11-13,17,22H,3-4,6,9-10,14-16,18H2,1H3,(H,36,37)(H,40,41) WKYSHCNOGACJHS-UHFFFAOYSA-N 562368 (rac)-4-chloro-14-cyclopropyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 41 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 19000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562368&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591571 472623934 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188297 Cc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClFN4O5S/c1-20-30-28(37-38(20)2)19-40(23-10-11-23)46(43,44)17-5-15-39-32-26(13-14-27(35)31(30)32)25(33(39)34(41)42)7-4-16-45-29-8-3-6-21-18-22(36)9-12-24(21)29/h3,6,8-9,12-14,18,23H,4-5,7,10-11,15-17,19H2,1-2H3,(H,41,42) KSYSWTYWPMVLRT-UHFFFAOYSA-N 562369 (−)-4-chloro-14-cyclopropyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide N-diethylamine salt (Enantiomer 1)::US11401278, Example 42 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.340 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562369&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 155123850 472623935 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188298 Cc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClFN4O5S/c1-20-30-28(37-38(20)2)19-40(23-10-11-23)46(43,44)17-5-15-39-32-26(13-14-27(35)31(30)32)25(33(39)34(41)42)7-4-16-45-29-8-3-6-21-18-22(36)9-12-24(21)29/h3,6,8-9,12-14,18,23H,4-5,7,10-11,15-17,19H2,1-2H3,(H,41,42) KSYSWTYWPMVLRT-UHFFFAOYSA-N 562369 (−)-4-chloro-14-cyclopropyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide N-diethylamine salt (Enantiomer 1)::US11401278, Example 42 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 12000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562369&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 155123850 472623935 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188299 Cc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClFN4O5S/c1-20-30-28(37-38(20)2)19-40(23-10-11-23)46(43,44)17-5-15-39-32-26(13-14-27(35)31(30)32)25(33(39)34(41)42)7-4-16-45-29-8-3-6-21-18-22(36)9-12-24(21)29/h3,6,8-9,12-14,18,23H,4-5,7,10-11,15-17,19H2,1-2H3,(H,41,42) KSYSWTYWPMVLRT-UHFFFAOYSA-N 562369 (−)-4-chloro-14-cyclopropyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide N-diethylamine salt (Enantiomer 1)::US11401278, Example 42 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 18000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562369&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 155123850 472623935 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188300 Cc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClFN4O5S/c1-20-30-28(37-38(20)2)19-40(23-10-11-23)46(43,44)17-5-15-39-32-26(13-14-27(35)31(30)32)25(33(39)34(41)42)7-4-16-45-29-8-3-6-21-18-22(36)9-12-24(21)29/h3,6,8-9,12-14,18,23H,4-5,7,10-11,15-17,19H2,1-2H3,(H,41,42) KSYSWTYWPMVLRT-UHFFFAOYSA-N 562370 (+)-4-chloro-14-cyclopropyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide N-diethylamine salt (Enantiomer 2)::US11401278, Example 43 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 6.20 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562370&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 155123850 472623936 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188301 Cc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClFN4O5S/c1-20-30-28(37-38(20)2)19-40(23-10-11-23)46(43,44)17-5-15-39-32-26(13-14-27(35)31(30)32)25(33(39)34(41)42)7-4-16-45-29-8-3-6-21-18-22(36)9-12-24(21)29/h3,6,8-9,12-14,18,23H,4-5,7,10-11,15-17,19H2,1-2H3,(H,41,42) KSYSWTYWPMVLRT-UHFFFAOYSA-N 562370 (+)-4-chloro-14-cyclopropyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide N-diethylamine salt (Enantiomer 2)::US11401278, Example 43 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562370&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 155123850 472623936 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188302 Cc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClFN4O5S/c1-20-30-28(37-38(20)2)19-40(23-10-11-23)46(43,44)17-5-15-39-32-26(13-14-27(35)31(30)32)25(33(39)34(41)42)7-4-16-45-29-8-3-6-21-18-22(36)9-12-24(21)29/h3,6,8-9,12-14,18,23H,4-5,7,10-11,15-17,19H2,1-2H3,(H,41,42) KSYSWTYWPMVLRT-UHFFFAOYSA-N 562370 (+)-4-chloro-14-cyclopropyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide N-diethylamine salt (Enantiomer 2)::US11401278, Example 43 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562370&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 155123850 472623936 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188303 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H45N5O6S/c1-26-34-31-14-7-13-29-30(15-8-22-49-33-16-6-11-27-10-4-5-12-28(27)33)37(38(44)45)43(36(29)31)18-9-25-50(46,47)41(3)32(35(34)39-40(26)2)17-19-42-20-23-48-24-21-42/h4-7,10-14,16,32H,8-9,15,17-25H2,1-3H3,(H,44,45) UNUQTFNLPJFUIF-UHFFFAOYSA-N 562371 (rac)-2,3,14-trimethyl-15-[2-(rac)-(morpholin-4-yl)ethyl]-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 44::US11401278, Example 45::US11401278, Example 46 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 3.00 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562371&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591602 472623937 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188304 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H45N5O6S/c1-26-34-31-14-7-13-29-30(15-8-22-49-33-16-6-11-27-10-4-5-12-28(27)33)37(38(44)45)43(36(29)31)18-9-25-50(46,47)41(3)32(35(34)39-40(26)2)17-19-42-20-23-48-24-21-42/h4-7,10-14,16,32H,8-9,15,17-25H2,1-3H3,(H,44,45) UNUQTFNLPJFUIF-UHFFFAOYSA-N 562371 (rac)-2,3,14-trimethyl-15-[2-(rac)-(morpholin-4-yl)ethyl]-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 44::US11401278, Example 45::US11401278, Example 46 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562371&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591602 472623937 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188305 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H45N5O6S/c1-26-34-31-14-7-13-29-30(15-8-22-49-33-16-6-11-27-10-4-5-12-28(27)33)37(38(44)45)43(36(29)31)18-9-25-50(46,47)41(3)32(35(34)39-40(26)2)17-19-42-20-23-48-24-21-42/h4-7,10-14,16,32H,8-9,15,17-25H2,1-3H3,(H,44,45) UNUQTFNLPJFUIF-UHFFFAOYSA-N 562371 (rac)-2,3,14-trimethyl-15-[2-(rac)-(morpholin-4-yl)ethyl]-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 44::US11401278, Example 45::US11401278, Example 46 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562371&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591602 472623937 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188306 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H45N5O6S/c1-26-34-31-14-7-13-29-30(15-8-22-49-33-16-6-11-27-10-4-5-12-28(27)33)37(38(44)45)43(36(29)31)18-9-25-50(46,47)41(3)32(35(34)39-40(26)2)17-19-42-20-23-48-24-21-42/h4-7,10-14,16,32H,8-9,15,17-25H2,1-3H3,(H,44,45) UNUQTFNLPJFUIF-UHFFFAOYSA-N 562371 (rac)-2,3,14-trimethyl-15-[2-(rac)-(morpholin-4-yl)ethyl]-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 44::US11401278, Example 45::US11401278, Example 46 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 33.0 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562371&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591602 472623937 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188307 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H45N5O6S/c1-26-34-31-14-7-13-29-30(15-8-22-49-33-16-6-11-27-10-4-5-12-28(27)33)37(38(44)45)43(36(29)31)18-9-25-50(46,47)41(3)32(35(34)39-40(26)2)17-19-42-20-23-48-24-21-42/h4-7,10-14,16,32H,8-9,15,17-25H2,1-3H3,(H,44,45) UNUQTFNLPJFUIF-UHFFFAOYSA-N 562371 (rac)-2,3,14-trimethyl-15-[2-(rac)-(morpholin-4-yl)ethyl]-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 44::US11401278, Example 45::US11401278, Example 46 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562371&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591602 472623937 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188308 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H45N5O6S/c1-26-34-31-14-7-13-29-30(15-8-22-49-33-16-6-11-27-10-4-5-12-28(27)33)37(38(44)45)43(36(29)31)18-9-25-50(46,47)41(3)32(35(34)39-40(26)2)17-19-42-20-23-48-24-21-42/h4-7,10-14,16,32H,8-9,15,17-25H2,1-3H3,(H,44,45) UNUQTFNLPJFUIF-UHFFFAOYSA-N 562371 (rac)-2,3,14-trimethyl-15-[2-(rac)-(morpholin-4-yl)ethyl]-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 44::US11401278, Example 45::US11401278, Example 46 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 18000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562371&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591602 472623937 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188309 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H45N5O6S/c1-26-34-31-14-7-13-29-30(15-8-22-49-33-16-6-11-27-10-4-5-12-28(27)33)37(38(44)45)43(36(29)31)18-9-25-50(46,47)41(3)32(35(34)39-40(26)2)17-19-42-20-23-48-24-21-42/h4-7,10-14,16,32H,8-9,15,17-25H2,1-3H3,(H,44,45) UNUQTFNLPJFUIF-UHFFFAOYSA-N 562371 (rac)-2,3,14-trimethyl-15-[2-(rac)-(morpholin-4-yl)ethyl]-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 44::US11401278, Example 45::US11401278, Example 46 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.310 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562371&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591602 472623937 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188310 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H45N5O6S/c1-26-34-31-14-7-13-29-30(15-8-22-49-33-16-6-11-27-10-4-5-12-28(27)33)37(38(44)45)43(36(29)31)18-9-25-50(46,47)41(3)32(35(34)39-40(26)2)17-19-42-20-23-48-24-21-42/h4-7,10-14,16,32H,8-9,15,17-25H2,1-3H3,(H,44,45) UNUQTFNLPJFUIF-UHFFFAOYSA-N 562371 (rac)-2,3,14-trimethyl-15-[2-(rac)-(morpholin-4-yl)ethyl]-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 44::US11401278, Example 45::US11401278, Example 46 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562371&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591602 472623937 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188311 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2cccc3c(CCCOc4cccc5ccccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H45N5O6S/c1-26-34-31-14-7-13-29-30(15-8-22-49-33-16-6-11-27-10-4-5-12-28(27)33)37(38(44)45)43(36(29)31)18-9-25-50(46,47)41(3)32(35(34)39-40(26)2)17-19-42-20-23-48-24-21-42/h4-7,10-14,16,32H,8-9,15,17-25H2,1-3H3,(H,44,45) UNUQTFNLPJFUIF-UHFFFAOYSA-N 562371 (rac)-2,3,14-trimethyl-15-[2-(rac)-(morpholin-4-yl)ethyl]-7-[3-(1-naphthyloxy)propyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 44::US11401278, Example 45::US11401278, Example 46 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562371&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591602 472623937 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188312 CN1CCC(N2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)42(2)16-14-31(35(33)41-43(24)3)44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) YJOFFNJPBZSEHT-UHFFFAOYSA-N 562374 (rac)-15-chloro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,13,14-trimethyl-11-(rac)-morpholino-5,6,9,10,11,13-hexahydro-4H,8H-pyrazolo[3′,4′:6,7][1]thia[2,10]diazacyclotridecino[8,9,10-hi]indole-2-carboxylic acid 7,7-dioxide (Mixture of Stereoisomers)::US11401278, Example 47 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.800 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562374&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591701 472623938 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188313 CN1CCC(N2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)42(2)16-14-31(35(33)41-43(24)3)44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) YJOFFNJPBZSEHT-UHFFFAOYSA-N 562374 (rac)-15-chloro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,13,14-trimethyl-11-(rac)-morpholino-5,6,9,10,11,13-hexahydro-4H,8H-pyrazolo[3′,4′:6,7][1]thia[2,10]diazacyclotridecino[8,9,10-hi]indole-2-carboxylic acid 7,7-dioxide (Mixture of Stereoisomers)::US11401278, Example 47 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562374&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591701 472623938 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188314 CN1CCC(N2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)42(2)16-14-31(35(33)41-43(24)3)44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) YJOFFNJPBZSEHT-UHFFFAOYSA-N 562374 (rac)-15-chloro-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,13,14-trimethyl-11-(rac)-morpholino-5,6,9,10,11,13-hexahydro-4H,8H-pyrazolo[3′,4′:6,7][1]thia[2,10]diazacyclotridecino[8,9,10-hi]indole-2-carboxylic acid 7,7-dioxide (Mixture of Stereoisomers)::US11401278, Example 47 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562374&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591701 472623938 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188315 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)43(3)31(35(33)41-42(24)2)14-16-44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) XSWCZTZLKYAUJL-UHFFFAOYSA-N 562377 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3,14-trimethyl-15-(rac)-[2-(morpholin-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 48::US11401278, Example 65::US11401278, Example 66::US11401278, Example 67 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.930 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562377&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591699 472623941 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188316 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)43(3)31(35(33)41-42(24)2)14-16-44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) XSWCZTZLKYAUJL-UHFFFAOYSA-N 562377 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3,14-trimethyl-15-(rac)-[2-(morpholin-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 48::US11401278, Example 65::US11401278, Example 66::US11401278, Example 67 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562377&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591699 472623941 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188317 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)43(3)31(35(33)41-42(24)2)14-16-44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) XSWCZTZLKYAUJL-UHFFFAOYSA-N 562377 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3,14-trimethyl-15-(rac)-[2-(morpholin-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 48::US11401278, Example 65::US11401278, Example 66::US11401278, Example 67 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562377&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591699 472623941 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188318 COc1ccc(CN2Cc3nn(C)c(C)c3-c3c(Cl)ccc4c(CCCOc5cccc6cc(F)ccc56)c(C(O)=O)n(CCCS2(=O)=O)c34)c(OC)c1 InChI=1S/C40H40ClFN4O7S/c1-24-36-33(43-44(24)2)23-45(22-26-11-13-28(51-3)21-35(26)52-4)54(49,50)19-7-17-46-38-31(15-16-32(41)37(36)38)30(39(46)40(47)48)9-6-18-53-34-10-5-8-25-20-27(42)12-14-29(25)34/h5,8,10-16,20-21H,6-7,9,17-19,22-23H2,1-4H3,(H,47,48) LPDSWYSBXDABNI-UHFFFAOYSA-N 562378 (rac)-4-chloro-14-(2,4-dimethoxybenzyl)-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 49 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 3.20 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562378&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 155123879 472623942 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188319 COc1ccc(CN2Cc3nn(C)c(C)c3-c3c(Cl)ccc4c(CCCOc5cccc6cc(F)ccc56)c(C(O)=O)n(CCCS2(=O)=O)c34)c(OC)c1 InChI=1S/C40H40ClFN4O7S/c1-24-36-33(43-44(24)2)23-45(22-26-11-13-28(51-3)21-35(26)52-4)54(49,50)19-7-17-46-38-31(15-16-32(41)37(36)38)30(39(46)40(47)48)9-6-18-53-34-10-5-8-25-20-27(42)12-14-29(25)34/h5,8,10-16,20-21H,6-7,9,17-19,22-23H2,1-4H3,(H,47,48) LPDSWYSBXDABNI-UHFFFAOYSA-N 562378 (rac)-4-chloro-14-(2,4-dimethoxybenzyl)-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 49 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562378&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 155123879 472623942 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188320 COc1ccc(CN2Cc3nn(C)c(C)c3-c3c(Cl)ccc4c(CCCOc5cccc6cc(F)ccc56)c(C(O)=O)n(CCCS2(=O)=O)c34)c(OC)c1 InChI=1S/C40H40ClFN4O7S/c1-24-36-33(43-44(24)2)23-45(22-26-11-13-28(51-3)21-35(26)52-4)54(49,50)19-7-17-46-38-31(15-16-32(41)37(36)38)30(39(46)40(47)48)9-6-18-53-34-10-5-8-25-20-27(42)12-14-29(25)34/h5,8,10-16,20-21H,6-7,9,17-19,22-23H2,1-4H3,(H,47,48) LPDSWYSBXDABNI-UHFFFAOYSA-N 562378 (rac)-4-chloro-14-(2,4-dimethoxybenzyl)-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 49 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562378&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 155123879 472623942 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188321 Cc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H30ClFN4O5S/c1-18-27-25(35-36(18)2)17-34-43(40,41)15-5-13-37-29-23(11-12-24(32)28(27)29)22(30(37)31(38)39)7-4-14-42-26-8-3-6-19-16-20(33)9-10-21(19)26/h3,6,8-12,16,34H,4-5,7,13-15,17H2,1-2H3,(H,38,39) QXJCJEZEPLEAGB-UHFFFAOYSA-N 562379 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 50::US11401278, Example 51::US11401278, Example 52 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.740 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562379&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591668 472623943 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188322 Cc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H30ClFN4O5S/c1-18-27-25(35-36(18)2)17-34-43(40,41)15-5-13-37-29-23(11-12-24(32)28(27)29)22(30(37)31(38)39)7-4-14-42-26-8-3-6-19-16-20(33)9-10-21(19)26/h3,6,8-12,16,34H,4-5,7,13-15,17H2,1-2H3,(H,38,39) QXJCJEZEPLEAGB-UHFFFAOYSA-N 562379 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 50::US11401278, Example 51::US11401278, Example 52 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562379&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591668 472623943 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188323 Cc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H30ClFN4O5S/c1-18-27-25(35-36(18)2)17-34-43(40,41)15-5-13-37-29-23(11-12-24(32)28(27)29)22(30(37)31(38)39)7-4-14-42-26-8-3-6-19-16-20(33)9-10-21(19)26/h3,6,8-12,16,34H,4-5,7,13-15,17H2,1-2H3,(H,38,39) QXJCJEZEPLEAGB-UHFFFAOYSA-N 562379 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 50::US11401278, Example 51::US11401278, Example 52 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562379&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591668 472623943 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188324 Cc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H30ClFN4O5S/c1-18-27-25(35-36(18)2)17-34-43(40,41)15-5-13-37-29-23(11-12-24(32)28(27)29)22(30(37)31(38)39)7-4-14-42-26-8-3-6-19-16-20(33)9-10-21(19)26/h3,6,8-12,16,34H,4-5,7,13-15,17H2,1-2H3,(H,38,39) QXJCJEZEPLEAGB-UHFFFAOYSA-N 562379 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 50::US11401278, Example 51::US11401278, Example 52 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.960 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562379&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591668 472623943 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188325 Cc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H30ClFN4O5S/c1-18-27-25(35-36(18)2)17-34-43(40,41)15-5-13-37-29-23(11-12-24(32)28(27)29)22(30(37)31(38)39)7-4-14-42-26-8-3-6-19-16-20(33)9-10-21(19)26/h3,6,8-12,16,34H,4-5,7,13-15,17H2,1-2H3,(H,38,39) QXJCJEZEPLEAGB-UHFFFAOYSA-N 562379 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 50::US11401278, Example 51::US11401278, Example 52 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562379&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591668 472623943 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188326 Cc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H30ClFN4O5S/c1-18-27-25(35-36(18)2)17-34-43(40,41)15-5-13-37-29-23(11-12-24(32)28(27)29)22(30(37)31(38)39)7-4-14-42-26-8-3-6-19-16-20(33)9-10-21(19)26/h3,6,8-12,16,34H,4-5,7,13-15,17H2,1-2H3,(H,38,39) QXJCJEZEPLEAGB-UHFFFAOYSA-N 562379 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 50::US11401278, Example 51::US11401278, Example 52 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562379&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591668 472623943 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188327 Cc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H30ClFN4O5S/c1-18-27-25(35-36(18)2)17-34-43(40,41)15-5-13-37-29-23(11-12-24(32)28(27)29)22(30(37)31(38)39)7-4-14-42-26-8-3-6-19-16-20(33)9-10-21(19)26/h3,6,8-12,16,34H,4-5,7,13-15,17H2,1-2H3,(H,38,39) QXJCJEZEPLEAGB-UHFFFAOYSA-N 562379 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 50::US11401278, Example 51::US11401278, Example 52 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 23.0 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562379&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591668 472623943 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188328 Cc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H30ClFN4O5S/c1-18-27-25(35-36(18)2)17-34-43(40,41)15-5-13-37-29-23(11-12-24(32)28(27)29)22(30(37)31(38)39)7-4-14-42-26-8-3-6-19-16-20(33)9-10-21(19)26/h3,6,8-12,16,34H,4-5,7,13-15,17H2,1-2H3,(H,38,39) QXJCJEZEPLEAGB-UHFFFAOYSA-N 562379 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 50::US11401278, Example 51::US11401278, Example 52 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562379&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591668 472623943 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188329 Cc1c-2c(CNS(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H30ClFN4O5S/c1-18-27-25(35-36(18)2)17-34-43(40,41)15-5-13-37-29-23(11-12-24(32)28(27)29)22(30(37)31(38)39)7-4-14-42-26-8-3-6-19-16-20(33)9-10-21(19)26/h3,6,8-12,16,34H,4-5,7,13-15,17H2,1-2H3,(H,38,39) QXJCJEZEPLEAGB-UHFFFAOYSA-N 562379 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 50::US11401278, Example 51::US11401278, Example 52 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 16000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562379&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591668 472623943 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188330 CCc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClFN4O5S/c1-3-29-32-28(38-39(29)2)20-41(23-11-12-23)47(44,45)18-6-16-40-33-26(14-15-27(36)31(32)33)25(34(40)35(42)43)8-5-17-46-30-9-4-7-21-19-22(37)10-13-24(21)30/h4,7,9-10,13-15,19,23H,3,5-6,8,11-12,16-18,20H2,1-2H3,(H,42,43) COFIAJOTHUPGLZ-UHFFFAOYSA-N 562382 (rac)-4-chloro-14-cyclopropyl-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 53 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.70 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562382&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591645 472623944 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188331 CCc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClFN4O5S/c1-3-29-32-28(38-39(29)2)20-41(23-11-12-23)47(44,45)18-6-16-40-33-26(14-15-27(36)31(32)33)25(34(40)35(42)43)8-5-17-46-30-9-4-7-21-19-22(37)10-13-24(21)30/h4,7,9-10,13-15,19,23H,3,5-6,8,11-12,16-18,20H2,1-2H3,(H,42,43) COFIAJOTHUPGLZ-UHFFFAOYSA-N 562382 (rac)-4-chloro-14-cyclopropyl-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 53 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 14000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562382&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591645 472623944 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188332 CCc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClFN4O5S/c1-3-29-32-28(38-39(29)2)20-41(23-11-12-23)47(44,45)18-6-16-40-33-26(14-15-27(36)31(32)33)25(34(40)35(42)43)8-5-17-46-30-9-4-7-21-19-22(37)10-13-24(21)30/h4,7,9-10,13-15,19,23H,3,5-6,8,11-12,16-18,20H2,1-2H3,(H,42,43) COFIAJOTHUPGLZ-UHFFFAOYSA-N 562382 (rac)-4-chloro-14-cyclopropyl-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 53 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 16000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562382&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591645 472623944 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188333 CCc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClFN4O5S/c1-3-29-32-28(38-39(29)2)20-41(23-11-12-23)47(44,45)18-6-16-40-33-26(14-15-27(36)31(32)33)25(34(40)35(42)43)8-5-17-46-30-9-4-7-21-19-22(37)10-13-24(21)30/h4,7,9-10,13-15,19,23H,3,5-6,8,11-12,16-18,20H2,1-2H3,(H,42,43) COFIAJOTHUPGLZ-UHFFFAOYSA-N 562383 (+)-4-chloro-14-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid N-ethylethanamine Salt (Enantiomer 1)::US11401278, Example 54 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.640 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562383&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591645 472623945 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188334 CCc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClFN4O5S/c1-3-29-32-28(38-39(29)2)20-41(23-11-12-23)47(44,45)18-6-16-40-33-26(14-15-27(36)31(32)33)25(34(40)35(42)43)8-5-17-46-30-9-4-7-21-19-22(37)10-13-24(21)30/h4,7,9-10,13-15,19,23H,3,5-6,8,11-12,16-18,20H2,1-2H3,(H,42,43) COFIAJOTHUPGLZ-UHFFFAOYSA-N 562383 (+)-4-chloro-14-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid N-ethylethanamine Salt (Enantiomer 1)::US11401278, Example 54 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 16000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562383&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591645 472623945 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188335 CCc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClFN4O5S/c1-3-29-32-28(38-39(29)2)20-41(23-11-12-23)47(44,45)18-6-16-40-33-26(14-15-27(36)31(32)33)25(34(40)35(42)43)8-5-17-46-30-9-4-7-21-19-22(37)10-13-24(21)30/h4,7,9-10,13-15,19,23H,3,5-6,8,11-12,16-18,20H2,1-2H3,(H,42,43) COFIAJOTHUPGLZ-UHFFFAOYSA-N 562384 (+)-4-chloro-14-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid N-ethylethanamine Salt (Enantiomer 2)::US11401278, Example 55 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 16.0 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562384&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591645 472623946 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188336 CCc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClFN4O5S/c1-3-29-32-28(38-39(29)2)20-41(23-11-12-23)47(44,45)18-6-16-40-33-26(14-15-27(36)31(32)33)25(34(40)35(42)43)8-5-17-46-30-9-4-7-21-19-22(37)10-13-24(21)30/h4,7,9-10,13-15,19,23H,3,5-6,8,11-12,16-18,20H2,1-2H3,(H,42,43) COFIAJOTHUPGLZ-UHFFFAOYSA-N 562384 (+)-4-chloro-14-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid N-ethylethanamine Salt (Enantiomer 2)::US11401278, Example 55 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 16000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562384&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591645 472623946 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188337 CCc1c-2c(CN(C3CC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClFN4O5S/c1-3-29-32-28(38-39(29)2)20-41(23-11-12-23)47(44,45)18-6-16-40-33-26(14-15-27(36)31(32)33)25(34(40)35(42)43)8-5-17-46-30-9-4-7-21-19-22(37)10-13-24(21)30/h4,7,9-10,13-15,19,23H,3,5-6,8,11-12,16-18,20H2,1-2H3,(H,42,43) COFIAJOTHUPGLZ-UHFFFAOYSA-N 562384 (+)-4-chloro-14-cyclopropyl-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid N-ethylethanamine Salt (Enantiomer 2)::US11401278, Example 55 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 13000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562384&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591645 472623946 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188338 CCN1Cc2nn(C)c(CC)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C34H36ClFN4O5S/c1-4-28-31-27(37-38(28)3)20-39(5-2)46(43,44)18-8-16-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-7-17-45-29-11-6-9-21-19-22(36)12-13-23(21)29/h6,9,11-15,19H,4-5,7-8,10,16-18,20H2,1-3H3,(H,41,42) VJZQVIHVPSHCPC-UHFFFAOYSA-N 562385 (rac)-4-chloro-3,14-diethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 56 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 2.10 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562385&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591636 472623947 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188339 CCN1Cc2nn(C)c(CC)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C34H36ClFN4O5S/c1-4-28-31-27(37-38(28)3)20-39(5-2)46(43,44)18-8-16-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-7-17-45-29-11-6-9-21-19-22(36)12-13-23(21)29/h6,9,11-15,19H,4-5,7-8,10,16-18,20H2,1-3H3,(H,41,42) VJZQVIHVPSHCPC-UHFFFAOYSA-N 562385 (rac)-4-chloro-3,14-diethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 56 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 14000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562385&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591636 472623947 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188340 CCN1Cc2nn(C)c(CC)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C34H36ClFN4O5S/c1-4-28-31-27(37-38(28)3)20-39(5-2)46(43,44)18-8-16-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-7-17-45-29-11-6-9-21-19-22(36)12-13-23(21)29/h6,9,11-15,19H,4-5,7-8,10,16-18,20H2,1-3H3,(H,41,42) VJZQVIHVPSHCPC-UHFFFAOYSA-N 562385 (rac)-4-chloro-3,14-diethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 56 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 16000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562385&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591636 472623947 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188341 CCN1Cc2nn(C)c(CC)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C34H36ClFN4O5S/c1-4-28-31-27(37-38(28)3)20-39(5-2)46(43,44)18-8-16-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-7-17-45-29-11-6-9-21-19-22(36)12-13-23(21)29/h6,9,11-15,19H,4-5,7-8,10,16-18,20H2,1-3H3,(H,41,42) VJZQVIHVPSHCPC-UHFFFAOYSA-N 562386 (+)-4-chloro-3,14-diethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid N-ethylethanamine Salt (Enantiomer 1)::US11401278, Example 57 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.480 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562386&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591636 472623948 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188342 CCN1Cc2nn(C)c(CC)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C34H36ClFN4O5S/c1-4-28-31-27(37-38(28)3)20-39(5-2)46(43,44)18-8-16-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-7-17-45-29-11-6-9-21-19-22(36)12-13-23(21)29/h6,9,11-15,19H,4-5,7-8,10,16-18,20H2,1-3H3,(H,41,42) VJZQVIHVPSHCPC-UHFFFAOYSA-N 562386 (+)-4-chloro-3,14-diethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid N-ethylethanamine Salt (Enantiomer 1)::US11401278, Example 57 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 12000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562386&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591636 472623948 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188343 CCN1Cc2nn(C)c(CC)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C34H36ClFN4O5S/c1-4-28-31-27(37-38(28)3)20-39(5-2)46(43,44)18-8-16-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-7-17-45-29-11-6-9-21-19-22(36)12-13-23(21)29/h6,9,11-15,19H,4-5,7-8,10,16-18,20H2,1-3H3,(H,41,42) VJZQVIHVPSHCPC-UHFFFAOYSA-N 562386 (+)-4-chloro-3,14-diethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid N-ethylethanamine Salt (Enantiomer 1)::US11401278, Example 57 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562386&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591636 472623948 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188344 CCN1Cc2nn(C)c(CC)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C34H36ClFN4O5S/c1-4-28-31-27(37-38(28)3)20-39(5-2)46(43,44)18-8-16-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-7-17-45-29-11-6-9-21-19-22(36)12-13-23(21)29/h6,9,11-15,19H,4-5,7-8,10,16-18,20H2,1-3H3,(H,41,42) VJZQVIHVPSHCPC-UHFFFAOYSA-N 562387 (+)-4-chloro-3,14-diethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid N-ethylethanamine Salt (Enantiomer 2)::US11401278, Example 58 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 28.0 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562387&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591636 472623949 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188345 CCN1Cc2nn(C)c(CC)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C34H36ClFN4O5S/c1-4-28-31-27(37-38(28)3)20-39(5-2)46(43,44)18-8-16-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-7-17-45-29-11-6-9-21-19-22(36)12-13-23(21)29/h6,9,11-15,19H,4-5,7-8,10,16-18,20H2,1-3H3,(H,41,42) VJZQVIHVPSHCPC-UHFFFAOYSA-N 562387 (+)-4-chloro-3,14-diethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid N-ethylethanamine Salt (Enantiomer 2)::US11401278, Example 58 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 13000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562387&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591636 472623949 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188346 CCN1Cc2nn(C)c(CC)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C34H36ClFN4O5S/c1-4-28-31-27(37-38(28)3)20-39(5-2)46(43,44)18-8-16-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-7-17-45-29-11-6-9-21-19-22(36)12-13-23(21)29/h6,9,11-15,19H,4-5,7-8,10,16-18,20H2,1-3H3,(H,41,42) VJZQVIHVPSHCPC-UHFFFAOYSA-N 562387 (+)-4-chloro-3,14-diethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid N-ethylethanamine Salt (Enantiomer 2)::US11401278, Example 58 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 14000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562387&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591636 472623949 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188347 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562388 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-15-[2-(tetrahydro-2H-pyran-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Racemate 2)::US11401278, Example 59 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.90 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562388&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623950 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188348 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562388 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-15-[2-(tetrahydro-2H-pyran-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Racemate 2)::US11401278, Example 59 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 17000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562388&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623950 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188349 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562388 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-15-[2-(tetrahydro-2H-pyran-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Racemate 2)::US11401278, Example 59 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 16000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562388&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623950 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188350 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562389 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-15-[2-(tetrahydro-2H-pyran-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Racemate 1)::US11401278, Example 60 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 2.40 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562389&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623951 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188351 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562389 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-15-[2-(tetrahydro-2H-pyran-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Racemate 1)::US11401278, Example 60 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562389&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623951 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188352 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562390 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 61 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.940 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562390&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623952 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188353 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562390 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 61 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 16000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562390&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623952 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188354 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562390 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 1)::US11401278, Example 61 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562390&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623952 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188355 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562391 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 62 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 110 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562391&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623953 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188356 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562391 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 62 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 14000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562391&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623953 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188357 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562391 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 2)::US11401278, Example 62 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 18000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562391&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623953 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188358 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562392 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 3)::US11401278, Example 63 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.10 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562392&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623954 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188359 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562392 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 3)::US11401278, Example 63 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 19000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562392&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623954 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188360 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562392 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 3)::US11401278, Example 63 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens 19000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562392&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623954 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188361 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562393 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 4)::US11401278, Example 64 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 21.0 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562393&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623955 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188362 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562393 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 4)::US11401278, Example 64 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562393&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623955 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188363 CCc1c-2c(nn1C)C(CCC1CCOCC1)N(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O6S/c1-4-32-36-35-31(41)15-14-30-29(9-6-20-52-34-10-5-8-26-24-27(42)12-13-28(26)34)39(40(47)48)46(38(30)35)19-7-23-53(49,50)45(3)33(37(36)43-44(32)2)16-11-25-17-21-51-22-18-25/h5,8,10,12-15,24-25,33H,4,6-7,9,11,16-23H2,1-3H3,(H,47,48) LAWVJPDUZILMPR-UHFFFAOYSA-N 562393 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(oxan-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Enantiomer 4)::US11401278, Example 64 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562393&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591656 472623955 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188364 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)43(3)31(35(33)41-42(24)2)14-16-44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) XSWCZTZLKYAUJL-UHFFFAOYSA-N 562377 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3,14-trimethyl-15-(rac)-[2-(morpholin-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 48::US11401278, Example 65::US11401278, Example 66::US11401278, Example 67 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.940 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562377&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591699 472623941 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188365 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)43(3)31(35(33)41-42(24)2)14-16-44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) XSWCZTZLKYAUJL-UHFFFAOYSA-N 562377 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3,14-trimethyl-15-(rac)-[2-(morpholin-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 48::US11401278, Example 65::US11401278, Example 66::US11401278, Example 67 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562377&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591699 472623941 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188366 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)43(3)31(35(33)41-42(24)2)14-16-44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) XSWCZTZLKYAUJL-UHFFFAOYSA-N 562377 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3,14-trimethyl-15-(rac)-[2-(morpholin-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 48::US11401278, Example 65::US11401278, Example 66::US11401278, Example 67 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562377&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591699 472623941 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188367 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)43(3)31(35(33)41-42(24)2)14-16-44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) XSWCZTZLKYAUJL-UHFFFAOYSA-N 562377 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3,14-trimethyl-15-(rac)-[2-(morpholin-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 48::US11401278, Example 65::US11401278, Example 66::US11401278, Example 67 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 22.0 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562377&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591699 472623941 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188368 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)43(3)31(35(33)41-42(24)2)14-16-44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) XSWCZTZLKYAUJL-UHFFFAOYSA-N 562377 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3,14-trimethyl-15-(rac)-[2-(morpholin-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 48::US11401278, Example 65::US11401278, Example 66::US11401278, Example 67 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562377&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591699 472623941 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188369 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)43(3)31(35(33)41-42(24)2)14-16-44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) XSWCZTZLKYAUJL-UHFFFAOYSA-N 562377 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3,14-trimethyl-15-(rac)-[2-(morpholin-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 48::US11401278, Example 65::US11401278, Example 66::US11401278, Example 67 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562377&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591699 472623941 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188370 CN1C(CCN2CCOCC2)c2nn(C)c(C)c2-c2c(Cl)ccc3c(CCCOc4cccc5cc(F)ccc45)c(C(O)=O)n(CCCS1(=O)=O)c23 InChI=1S/C38H43ClFN5O6S/c1-24-33-34-30(39)13-12-29-28(8-5-19-51-32-9-4-7-25-23-26(40)10-11-27(25)32)37(38(46)47)45(36(29)34)15-6-22-52(48,49)43(3)31(35(33)41-42(24)2)14-16-44-17-20-50-21-18-44/h4,7,9-13,23,31H,5-6,8,14-22H2,1-3H3,(H,46,47) XSWCZTZLKYAUJL-UHFFFAOYSA-N 562377 (rac)-4-chloro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,3,14-trimethyl-15-(rac)-[2-(morpholin-4-yl)ethyl]-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3′,4′:4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide (Mixture of Stereoisomers)::US11401278, Example 48::US11401278, Example 65::US11401278, Example 66::US11401278, Example 67 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.400 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562377&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591699 472623941 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188371 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562397 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 68 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.90 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562397&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623956 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188372 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562397 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 68 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562397&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623956 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188373 CCc1c-2c(CN(C)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O5S/c1-4-27-30-26(36-38(27)3)19-37(2)45(42,43)17-7-15-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-16-44-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) DGORHTLPMAKQCY-UHFFFAOYSA-N 562397 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-11,12,14,15-tetrahydro-2H,10H-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid 13,13-dioxide::US11401278, Example 68 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562397&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591575 472623956 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 1188374 CCc1c-2c(nn1C)C(CCN(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)N1CCOCC1 InChI=1S/C39H45ClFN5O6S/c1-4-31-35-34-30(40)14-13-29-28(9-6-20-52-33-10-5-8-25-24-26(41)11-12-27(25)33)38(39(47)48)46(37(29)34)16-7-23-53(49,50)43(2)17-15-32(36(35)42-44(31)3)45-18-21-51-22-19-45/h5,8,10-14,24,32H,4,6-7,9,15-23H2,1-3H3,(H,47,48) SOSFJVGXMDRHJQ-UHFFFAOYSA-N 562398 (rac)-15-chloro-14-ethyl-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-8,13-dimethyl-11-(rac)-morpholino-5,6,9,10,11,13-hexahydro-4H,8H-pyrazolo[3',4':6,7][1]thia[2,10]diazacyclotridecino[8,9,10-hi]indole-2-carboxylic acid 7,7-dioxide (Mixture of Stereoisomers)::US11401278, Example 69 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.50 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562398&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591669 472623957 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188375 CCc1c-2c(nn1C)C(CCN(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)N1CCOCC1 InChI=1S/C39H45ClFN5O6S/c1-4-31-35-34-30(40)14-13-29-28(9-6-20-52-33-10-5-8-25-24-26(41)11-12-27(25)33)38(39(47)48)46(37(29)34)16-7-23-53(49,50)43(2)17-15-32(36(35)42-44(31)3)45-18-21-51-22-19-45/h5,8,10-14,24,32H,4,6-7,9,15-23H2,1-3H3,(H,47,48) SOSFJVGXMDRHJQ-UHFFFAOYSA-N 562399 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-17-(morpholin-4-yl)-11,12,14,15,16,17-hexahydro-2H,10H-pyrazolo[3',4':6,7][1,2,10]thiadiazacyclotridecino[8,9,10-hi]indole-8-carboxylic acid 13,13-dioxide trifluoroacetate salt (Enantiomer 1)::US11401278, Example 70 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 86.0 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562399&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591669 472623958 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188376 CCc1c-2c(nn1C)C(CCN(C)S(=O)(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13)N1CCOCC1 InChI=1S/C39H45ClFN5O6S/c1-4-31-35-34-30(40)14-13-29-28(9-6-20-52-33-10-5-8-25-24-26(41)11-12-27(25)33)38(39(47)48)46(37(29)34)16-7-23-53(49,50)43(2)17-15-32(36(35)42-44(31)3)45-18-21-51-22-19-45/h5,8,10-14,24,32H,4,6-7,9,15-23H2,1-3H3,(H,47,48) SOSFJVGXMDRHJQ-UHFFFAOYSA-N 562400 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-17-(morpholin-4-yl)-11,12,14,15,16,17-hexahydro-2H,10H-pyrazolo[3',4':6,7][1,2,10]thiadiazacyclotridecino[8,9,10-hi]indole-8-carboxylic acid 13,13-dioxide trifluoroacetate salt (Enantiomer 2)::US11401278, Example 71 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.800 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562400&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591669 472623959 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188377 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)S(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H45ClFN5O5S/c1-4-31-35-34-30(40)14-13-29-28(9-6-20-51-33-10-5-8-25-24-26(41)11-12-27(25)33)38(39(47)48)46(37(29)34)16-7-23-52(49)44(3)32(36(35)42-43(31)2)15-17-45-18-21-50-22-19-45/h5,8,10-14,24,32H,4,6-7,9,15-23H2,1-3H3,(H,47,48) HBYNIRIJMNNPHV-UHFFFAOYSA-N 562401 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(morpholin-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Mixture of Stereoisomers)::US11401278, Example 72::US11401278, Example 73::US11401278, Example 74::US11401278, Example 75::US11401278, Example 76 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.10 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562401&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591651 472623960 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188378 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)S(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H45ClFN5O5S/c1-4-31-35-34-30(40)14-13-29-28(9-6-20-51-33-10-5-8-25-24-26(41)11-12-27(25)33)38(39(47)48)46(37(29)34)16-7-23-52(49)44(3)32(36(35)42-43(31)2)15-17-45-18-21-50-22-19-45/h5,8,10-14,24,32H,4,6-7,9,15-23H2,1-3H3,(H,47,48) HBYNIRIJMNNPHV-UHFFFAOYSA-N 562401 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(morpholin-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Mixture of Stereoisomers)::US11401278, Example 72::US11401278, Example 73::US11401278, Example 74::US11401278, Example 75::US11401278, Example 76 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.340 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562401&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591651 472623960 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188379 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)S(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H45ClFN5O5S/c1-4-31-35-34-30(40)14-13-29-28(9-6-20-51-33-10-5-8-25-24-26(41)11-12-27(25)33)38(39(47)48)46(37(29)34)16-7-23-52(49)44(3)32(36(35)42-43(31)2)15-17-45-18-21-50-22-19-45/h5,8,10-14,24,32H,4,6-7,9,15-23H2,1-3H3,(H,47,48) HBYNIRIJMNNPHV-UHFFFAOYSA-N 562401 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(morpholin-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Mixture of Stereoisomers)::US11401278, Example 72::US11401278, Example 73::US11401278, Example 74::US11401278, Example 75::US11401278, Example 76 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 1.10 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562401&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591651 472623960 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188380 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)S(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H45ClFN5O5S/c1-4-31-35-34-30(40)14-13-29-28(9-6-20-51-33-10-5-8-25-24-26(41)11-12-27(25)33)38(39(47)48)46(37(29)34)16-7-23-52(49)44(3)32(36(35)42-43(31)2)15-17-45-18-21-50-22-19-45/h5,8,10-14,24,32H,4,6-7,9,15-23H2,1-3H3,(H,47,48) HBYNIRIJMNNPHV-UHFFFAOYSA-N 562401 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(morpholin-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Mixture of Stereoisomers)::US11401278, Example 72::US11401278, Example 73::US11401278, Example 74::US11401278, Example 75::US11401278, Example 76 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 150 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562401&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591651 472623960 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188381 CCc1c-2c(nn1C)C(CCN1CCOCC1)N(C)S(=O)CCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C39H45ClFN5O5S/c1-4-31-35-34-30(40)14-13-29-28(9-6-20-51-33-10-5-8-25-24-26(41)11-12-27(25)33)38(39(47)48)46(37(29)34)16-7-23-52(49)44(3)32(36(35)42-43(31)2)15-17-45-18-21-50-22-19-45/h5,8,10-14,24,32H,4,6-7,9,15-23H2,1-3H3,(H,47,48) HBYNIRIJMNNPHV-UHFFFAOYSA-N 562401 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-15-[2-(morpholin-4-yl)ethyl]-13,13-dioxo-10,11,12,13,14,15-hexahydro-2H-13lambda6-pyrazolo[3',4':4,5][1,2,8]thiadiazacycloundecino[6,7,8-hi]indole-8-carboxylic acid (Mixture of Stereoisomers)::US11401278, Example 72::US11401278, Example 73::US11401278, Example 74::US11401278, Example 75::US11401278, Example 76 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 0.590 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562401&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591651 472623960 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188382 CCc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C38H43ClFN5O6S/c1-3-32-35-31(41-42(32)2)24-44(16-15-43-17-20-50-21-18-43)52(48,49)22-6-14-45-36-29(12-13-30(39)34(35)36)28(37(45)38(46)47)8-5-19-51-33-9-4-7-25-23-26(40)10-11-27(25)33/h4,7,9-13,23H,3,5-6,8,14-22,24H2,1-2H3,(H,46,47) UMJXVWFWRJSDIQ-UHFFFAOYSA-N 562406 (rac)-13-chloro-12-ethyl-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-8-(2-morpholinoethyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3',4':4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 77 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-329]/Phorbol-Phorbol-12-myristate-13-acetate-induced protein 1 [26-43] Human 6.20 US Patent 10.7270/Q2930XCJ aid1806690 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=128&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562406&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-329%5D%2FPhorbol-Phorbol-12-myristate-13-acetate-induced+protein+1+%5B26-43%5D&column=ki&startPg=0&Increment=50&submit=Search 142591601 472623961 2 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIR 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 ATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1188383 CCc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C38H43ClFN5O6S/c1-3-32-35-31(41-42(32)2)24-44(16-15-43-17-20-50-21-18-43)52(48,49)22-6-14-45-36-29(12-13-30(39)34(35)36)28(37(45)38(46)47)8-5-19-51-33-9-4-7-25-23-26(40)10-11-27(25)33/h4,7,9-13,23H,3,5-6,8,14-22,24H2,1-2H3,(H,46,47) UMJXVWFWRJSDIQ-UHFFFAOYSA-N 562406 (rac)-13-chloro-12-ethyl-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-8-(2-morpholinoethyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3',4':4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 77 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2930XCJ aid1806691 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562406&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591601 472623961 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1188384 CCc1c-2c(CN(CCN3CCOCC3)S(=O)(=O)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C38H43ClFN5O6S/c1-3-32-35-31(41-42(32)2)24-44(16-15-43-17-20-50-21-18-43)52(48,49)22-6-14-45-36-29(12-13-30(39)34(35)36)28(37(45)38(46)47)8-5-19-51-33-9-4-7-25-23-26(40)10-11-27(25)33/h4,7,9-13,23H,3,5-6,8,14-22,24H2,1-2H3,(H,46,47) UMJXVWFWRJSDIQ-UHFFFAOYSA-N 562406 (rac)-13-chloro-12-ethyl-1-(3-((6-fluoronaphthalen-1-yl)oxy)propyl)-11-methyl-8-(2-morpholinoethyl)-5,6,9,11-tetrahydro-4H,8H-pyrazolo[3',4':4,5][1]thia[2,8]diazacycloundecino[6,7,8-hi]indole-2-carboxylic acid 7,7-dioxide::US11401278, Example 77 Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N] Homo sapiens >20000 US Patent 10.7270/Q2930XCJ aid1806692 US11401278 Furst, L; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Wei, G; McCarren, PR; Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Monning, U; Nowak-Reppel, K 8/2/2022 10/23/2022 The Broad Institute, Inc.; Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=562406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=181&target=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=562406&enzyme=Bcl-2-like+protein+1%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591601 472623961 2 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6DCN,6DCO,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976